Accutar Biotech

Accutar Biotech

Drug discovery artificial intelligence company founded in 2015 by Jie Fan and Ke Liu.

All edits by  Khadidiatou Amirou 

Edits on 26 Jul, 2020
Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+13/-13 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu. It is headquartered in Shanghai, China, and maintains an additional office in New York City, United StatesUnited States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+15/-15 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu. It is headquartered in Shanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu TechnologyYitu Technology, and ZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+8/-8 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu. It is headquartered in Shanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFundZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+14/-14 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discoverydrug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu. It is headquartered in Shanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+8/-8 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu. It is headquartered in ShanghaiShanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou approved a suggestion from Golden's AI on 26 Jul, 2020
Edits made to:
Article (+16/-16 characters)
Article

Accutar Biotech's AI is made up of several components: Accutar Virtual Screen, Docking, Intelligent-SAR, and Chemi-Net. These integrated components are used to design novel drug compounds and are intended to be used during the drug developmentdrug development and preclinical trial phases. The virtual representation of protein-ligand bindings is conducted through Accular Virtual Screen and Docking. Intelligent-SAR generates novel compounds which are then validated through co-crystallization and binding assays. Its Chemi-Net platform uses a deep neural network to predict absorption, distribution, metabolism, and excretion (ADME) of these compounds.

Khadidiatou Amirou
Khadidiatou Amirou edited on 26 Jul, 2020
Edits made to:
Article (-5 characters)
Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu (cb). It is headquartered in Shanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFund.

Khadidiatou Amirou
Khadidiatou Amirou edited on 26 Jul, 2020
Edits made to:
Infobox (+10/--1 properties)
Description (+85 characters)
Article (+1019 characters)
Further reading (+2 rows) (+10 cells) (+415 characters)
Categories (+2 topics)
Topic thumbnail

Accutar Accutar Biotech

Drug discovery artificial intelligence company founded in 2015 by Jie Fan and Ke Liu.

Article

Accutar Biotech - also known as AccutarBio - is a company that develops a drug discovery artificial intelligence platform. It was founded in 2015 by Jie Fan, Ke Liu (cb). It is headquartered in Shanghai, China, and maintains an additional office in New York City, United States. The company has received funding from IDG Capital, Yitu Technology, and ZhenFund.

...
Product and service

Accutar Biotech's AI is made up of several components: Accutar Virtual Screen, Docking, Intelligent-SAR, and Chemi-Net. These integrated components are used to design novel drug compounds and are intended to be used during the drug development and preclinical trial phases. The virtual representation of protein-ligand bindings is conducted through Accular Virtual Screen and Docking. Intelligent-SAR generates novel compounds which are then validated through co-crystallization and binding assays. Its Chemi-Net platform uses a deep neural network to predict absorption, distribution, metabolism, and excretion (ADME) of these compounds.

Further reading

Title
Author
Link
Type
Date

AccutarBio Advances AI in Drug Discovery - SyncedReview - Medium

Synced

Web

May 1, 2018

Chemi-net: a graph convolutional network for accurate drug property prediction

Ke Liu, Xiangyan Sun, Lei Jia, Jun Ma, Haoming Xing, Junqiu Wu, Hua Gao, Yax Sun, Florian Boulnois, Jie Fan

Journal article

March 16, 2018

Infobox
CEO
Jie Fan
Company status
Active
Founded date
2015
Founder
Jie Fan
Investors
ZhenFund
Location
Shanghai
Place of incorporation
Delaware
Categories
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.